
Please try another search
Carna Biosciences, Inc., a clinical-stage biopharmaceutical company, discovers and develops drug therapies to treat unmet medical needs in Japan. Its products include kinase proteins, substrates, Luciferase PPI stable cell lines, kinase assay kits, peptide substrate, mobility shifty assay, and lipid kinase panels. The company also offers profiling, NanoBRET TE intracellular kinase cell-based assay, protein detection assays. It also focuses on developing products for the treatment of various diseases, such as AS-0141, an orally bioavailable small molecule inhibitor of CDC7 kinase that is in preclinical trials to treat cancer; AS-0871, a small molecule drug for inflammatory and immune disorders, which is in Phase 1 clinical trials; and AS-1763, an orally bioavailable and non-covalent inhibitor for the treatment of chronic lymphocytic leukemia and other B cell malignancies that is in preclinical trials. The company has collaborations with Sumitomo Pharma, Gilead Sciences. Carna Biosciences, Inc. was incorporated in 2003 and is based in Kobe, Japan.
Name | Age | Since | Title |
---|---|---|---|
Kohichiro Yoshino | 73 | 2003 | CEO, President & Representative Director |
Emi Yamamoto | 53 | 2015 | GM of Business Mgt., Accounting, HR, General Affairs, CFO, Director & President - CarnaBio USA |
Masaaki Sawa | 53 | 2015 | GM of Research & Development Division, Chief Scientific Officer and Director |
Takao Matsui | 69 | 2019 | Independent Outside Director |
Kaoru Suzuki | - | 2024 | Independent Outside Director |
Akinori Arimura | 62 | 2019 | GM of Clinical Development, R&D, Chief Development Officer of CarnaBio USA & Director |
Atsuo Arita | 82 | 2004 | Independent Outside Director |
Tsuguo Ogasawara | 86 | 2005 | Independent Outside Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review